secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001193125-23-200555
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant settles Illumina litigation, extends commercial partnership with three-year agreement
--------------------------------------------------------------------------------

- Guardant and Illumina agreed to dismiss with prejudice the March 2022 Delaware lawsuit, including all IP allegations.
- New three-year collaboration covers sharing of specimen samples for cancer research and a long-term purchase/supply commitment.
- The agreement extends the companies' longstanding commercial relationship; no financial terms disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523200555/0001193125-23-200555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312523200555/d542051d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-200555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer